Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHENYSE:DGXNYSE:DVANYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$565.32+1.7%$587.84$512.12▼$623.61$8.26B0.4998,797 shs115,588 shsDGXQuest Diagnostics$176.64+1.7%$169.06$134.50▼$178.87$18.33B0.78965,999 shs1.13 million shsDVADaVita$140.64+0.8%$146.22$131.27▼$179.60$11.25B1.04840,706 shs587,734 shsLHLaboratory Co. of America$230.45+0.9%$234.95$191.97▼$258.59$19.28B0.99633,708 shs983,764 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed+1.57%+0.36%-6.70%+0.74%+0.87%DGXQuest Diagnostics+1.66%+9.19%+5.59%+12.30%+31.57%DVADaVita+0.77%+5.17%-6.42%-18.79%+5.34%LHLaboratory Co. of America+0.81%+8.48%+0.31%-7.24%+16.16%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEChemed4.4835 of 5 stars2.53.03.34.92.12.51.3DGXQuest Diagnostics4.5509 of 5 stars2.33.04.24.72.62.51.3DVADaVita4.2761 of 5 stars2.03.00.04.52.91.73.1LHLaboratory Co. of America4.7169 of 5 stars3.43.02.54.23.42.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 3.00Buy$674.0019.22% UpsideDGXQuest Diagnostics 2.69Moderate Buy$185.074.77% UpsideDVADaVita 2.00Hold$166.3318.27% UpsideLHLaboratory Co. of America 2.87Moderate Buy$268.7716.63% UpsideCurrent Analyst Ratings BreakdownLatest DGX, LH, DVA, and CHE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025CHEChemedRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.004/28/2025DGXQuest DiagnosticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.004/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$182.00 ➝ $190.004/23/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$175.00 ➝ $180.004/23/2025DGXQuest DiagnosticsBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$175.00 ➝ $185.004/23/2025DGXQuest DiagnosticsRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$191.00 ➝ $194.004/11/2025LHLaboratory Co. of AmericaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$285.00 ➝ $274.004/10/2025LHLaboratory Co. of AmericaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$260.00 ➝ $240.004/9/2025DGXQuest DiagnosticsMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$178.00 ➝ $189.004/2/2025DGXQuest DiagnosticsRedburn PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$195.004/2/2025DGXQuest DiagnosticsRedburn AtlanticSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$195.00(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.49B3.32$25.24 per share22.40$73.55 per share7.69DGXQuest Diagnostics$10.16B1.94$13.78 per share12.82$61.04 per share2.89DVADaVita$12.82B0.88$18.43 per share7.63$4.95 per share28.41LHLaboratory Co. of America$13.01B1.48$20.78 per share11.09$96.27 per share2.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$272.51M$20.5328.5724.262.1512.69%27.86%19.12%N/ADGXQuest Diagnostics$871M$7.9122.9716.842.168.80%15.07%6.72%N/ADVADaVita$936.34M$10.7413.0911.071.077.31%115.48%4.94%5/1/2025 (Estimated)LHLaboratory Co. of America$746M$8.8226.1313.141.715.73%15.29%7.01%4/29/2025 (Estimated)Latest DGX, LH, DVA, and CHE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025DVADaVita$1.75N/AN/AN/A$3.22 billionN/A4/29/2025Q1 2025LHLaboratory Co. of America$3.75N/AN/AN/A$3.41 billionN/A4/23/2025Q1 2025CHEChemed$5.59$5.63+$0.04$4.86$641.78 million$646.94 million4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billion2/13/2025Q4 2024DVADaVita$2.14$2.24+$0.10$3.09$3.27 billionN/A2/6/2025Q4 2024LHLaboratory Co. of America$3.40$3.45+$0.05$1.70$3.31 billionN/A1/30/2025Q4 2024DGXQuest Diagnostics$2.19$2.23+$0.04$1.95$2.58 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.000.35%+8.74%9.74%16 YearsDGXQuest Diagnostics$3.201.81%+6.94%40.46%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLaboratory Co. of America$2.881.25%N/A32.65%N/ALatest DGX, LH, DVA, and CHE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/10/2025LHLaboratory Co. of Americaquarterly$0.721.25%5/29/20256/11/20251/30/2025DGXQuest Diagnosticsquarterly$0.802.06%4/7/20254/7/20254/21/20252/14/2025CHEChemedquarterly$0.500.36%2/24/20252/24/20253/14/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.851.81DGXQuest Diagnostics0.821.101.02DVADaVita23.181.261.21LHLaboratory Co. of America0.671.441.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLaboratory Co. of America95.94%Insider OwnershipCompanyInsider OwnershipCHEChemed3.29%DGXQuest Diagnostics8.16%DVADaVita2.00%LHLaboratory Co. of America0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed14,20014.62 million14.55 millionOptionableDGXQuest Diagnostics49,000111.61 million110.73 millionOptionableDVADaVita70,00080.00 million78.40 millionOptionableLHLaboratory Co. of America75,50083.67 million82.93 millionOptionableDVA, DGX, LH, and CHE HeadlinesRecent News About These Companies6LH : Earnings Preview: Laboratory CorpApril 28 at 2:58 PM | benzinga.comFuller & Thaler Asset Management Inc. Grows Stock Holdings in Laboratory Co. of America Holdings (NYSE:LH)April 28 at 5:27 AM | marketbeat.comHsbc Holdings PLC Has $37.18 Million Stake in Laboratory Co. of America Holdings (NYSE:LH)April 28 at 5:07 AM | marketbeat.comLabcorp (LH) Reports Q1: Everything You Need To Know Ahead Of EarningsApril 28 at 4:56 AM | finance.yahoo.comState of Tennessee Department of Treasury Purchases 5,454 Shares of Laboratory Co. of America Holdings (NYSE:LH)April 28 at 4:46 AM | marketbeat.comLord Abbett & CO. LLC Sells 126,638 Shares of Laboratory Co. of America Holdings (NYSE:LH)April 27 at 6:43 AM | marketbeat.comLaboratory Co. of America Holdings (NYSE:LH) Holdings Decreased by BI Asset Management Fondsmaeglerselskab A SApril 27 at 4:50 AM | marketbeat.comAnalysts Set Laboratory Co. of America Holdings (NYSE:LH) Target Price at $268.77April 27 at 2:57 AM | americanbankingnews.comLaboratory Co. of America Holdings (NYSE:LH) Position Trimmed by J. Safra Sarasin Holding AGApril 26 at 5:43 AM | marketbeat.comLaboratory Co. of America Holdings (NYSE:LH) Shares Acquired by NatixisApril 26 at 5:09 AM | marketbeat.comNewEdge Advisors LLC Increases Stock Position in Laboratory Co. of America Holdings (NYSE:LH)April 26 at 4:31 AM | marketbeat.comLaboratory Co. of America Holdings (NYSE:LH) Receives Consensus Rating of "Moderate Buy" from AnalystsApril 26 at 3:18 AM | marketbeat.comLabcorp acquires North Mississippi Health Services’ laboratory businessApril 24, 2025 | bizjournals.comLabcorp Holdings (NYSE:LH) Expands Precision Oncology Portfolio with FDA-Authorized Liquid Biopsy TestsApril 24, 2025 | finance.yahoo.comStifel Financial Corp Boosts Stake in Laboratory Co. of America Holdings (NYSE:LH)April 24, 2025 | marketbeat.comFreedom Investment Management Inc. Invests $379,000 in Laboratory Co. of America Holdings (NYSE:LH)April 24, 2025 | marketbeat.comLabcorp Launches Molecular Residual Disease and Liquid Biopsy SolutionsApril 23, 2025 | gurufocus.comLabcorp Launches Molecular Residual Disease and Liquid Biopsy SolutionsApril 23, 2025 | prnewswire.comDimensional Fund Advisors LP Lowers Position in Laboratory Co. of America Holdings (NYSE:LH)April 23, 2025 | marketbeat.comMariner LLC Buys 2,709 Shares of Laboratory Co. of America Holdings (NYSE:LH)April 23, 2025 | marketbeat.comLaboratory Co. of America (LH) to Release Earnings on TuesdayApril 23, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Buyable Stocks With Solid Bottoms Ready to ReboundBy Thomas Hughes | March 31, 2025View 3 Buyable Stocks With Solid Bottoms Ready to ReboundArcher Aviation’s Africa Deal Could Boost ACHR StockBy Jeffrey Neal Johnson | April 4, 2025View Archer Aviation’s Africa Deal Could Boost ACHR StockGame-Changing News for Advanced Micro Devices By Thomas Hughes | March 31, 2025View Game-Changing News for Advanced Micro Devices Joby Aviation: Operational Momentum vs. Market SentimentBy Jeffrey Neal Johnson | April 10, 2025View Joby Aviation: Operational Momentum vs. Market SentimentDow's Nuclear Gamble: A Bold Step in Turbulent TimesBy Jeffrey Neal Johnson | April 8, 2025View Dow's Nuclear Gamble: A Bold Step in Turbulent TimesDVA, DGX, LH, and CHE Company DescriptionsChemed NYSE:CHE$565.32 +9.58 (+1.72%) Closing price 04/28/2025 03:59 PM EasternExtended Trading$583.17 +17.85 (+3.16%) As of 04/28/2025 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$176.64 +2.88 (+1.66%) Closing price 04/28/2025 03:59 PM EasternExtended Trading$177.36 +0.73 (+0.41%) As of 04/28/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$140.64 +1.08 (+0.77%) Closing price 04/28/2025 03:59 PM EasternExtended Trading$139.80 -0.84 (-0.60%) As of 04/28/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Laboratory Co. of America NYSE:LH$230.45 +2.14 (+0.94%) Closing price 04/28/2025 03:59 PM EasternExtended Trading$226.09 -4.36 (-1.89%) As of 04/28/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Rebounds After Strong Earnings and Buyback Announcement Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret? The Bear Market Has Only Just Started - Here's Why MarketBeat Week in Review – 04/21 - 04/25 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. PepsiCo’s Stock Price is Disconnected From Reality: Time to Buy Bears Can Reap Big Benefits With These 3 Short ETF Bets Why Institutions Are Buying Super Micro Computer Stock Again Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
